AKT1 and neoplasm: Possible drug resistance mechanisms include EMT transitions; changes in the tumor microenvironment involve angiogenesis, inflammation, fibrosis, hypoxia, oxidative stress, autophagy, and activation of an escape pathway (like PI3K/Akt/mTOR) from the MAPK cascade [16].